Kraljevic Pavelic, S; Sedic, M; Hock, K; Vucinic, S; Jurisic, D; Gehrig, P; Scott, M; Schlapbach, R; Cacev, T; Kapitanovic, S; Pavelic, K (2008). An integrated proteomics approach for studying the molecular pathogenesis of Dupuytren's disease. Journal of Pathology, 217(4):524-533.
Sedic, M; Poznic, M; Gehrig, P; Scott, M; Schlapbach, R; Hranjec, M; Karminski-Zamola, G; Pavelic, K; Kraljevic Pavelic, S (2008). Differential antiproliferative mechanisms of novel derivative of benzimidazo[1,2-alpha]quinoline in colon cancer cells depending on their p53 status. Molecular Cancer Therapeutics, 7(7):2121-2132.
Kraljevic, S; Sedic, M; Scott, M; Gehrig, P; Schlapbach, R; Pavelic, K (2006). Casting light on molecular events underlying anti-cancer drug treatment: what can be seen from the proteomics point of view? Cancer Treatment Reviews, 32(8):619-629.